Title : Overview of cutaneous T-cell lymphoma: prognostic factors and novel therapeutic approaches.

Pub. Date : 2003

PMID : 15202526






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Among the novel therapies for CTCL is bexarotene, a retinoid X-receptor (RXR)-selective agonist, which has demonstrated efficacy in advanced refractory CTCL. Bexarotene TSPY like 2 Homo sapiens
2 Among the novel therapies for CTCL is bexarotene, a retinoid X-receptor (RXR)-selective agonist, which has demonstrated efficacy in advanced refractory CTCL. Bexarotene TSPY like 2 Homo sapiens